BRIEF: Bao Pharma doubles in Hong Kong trading debut
Shares Shanghai Bao Pharmaceuticals Co. Ltd. (2659.HK) opened up 128% in their Hong Kong trading debut on Wednesday, and held on to the gains during the morning session to close…
BRIEF: InSilico gets CSRC nod for Hong Kong IPO
AI drug discovery platform InSilico Medicine Cayman TopCo has been approved by China’s securities watchdog for a Hong Kong IPO, clearing a key hurdle in its stalled listing. According to…
INDUSTRY BRIEF: Healthcare stocks under pressure as national drug list expands
Many Hong Kong-listed drugmakers on Monday announced their products that were included in the 2025 edition of China’s National Reimbursement Drug List (NRDL), which was unveiled this week. The updated…
BRIEF: Bao Pharma launches $128 million Hong Kong IPO
Shanghai Bao Pharma Co. Ltd. (2659.HK) launched its Hong Kong IPO on Tuesday, planning to sell 37.9 million shares at an offer price of HK$26.38 per share, raising up to…
BRIEF: Wai Yuen Tong’s profit plunges in first half of fiscal year
Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) warned on Monday that it expects to report its profit plunged 87% year-on-year to HK$3 million ($390,000) or…
BRIEF: Venus Medtech sells Hangzhou project for 375 million yuan
Medical device maker Venus Medtech (Hangzhou) Inc. (2500.HK) announced on Tuesday that it will sell its Qiming Healthcare Life Science Industrial Park in Hangzhou, along with related land-use rights, to…
NEWS WRAP: MediTrust Health says AI to empower better decision-making for insurers
The healthcare payor platform’s founder and CEO Seth Zhang said AI can help insurance companies boost their efficiency, but achieving consistent accuracy is a key obstacle By Doug Young…
Recent Articles
RELATED ARTICLES
-
BRIEF: MicroPort ‘s revenue soars in first half of 2025
2252.HK
-
Feihe’s sliding profits point to China dairy market past its sell-by date
6186.HK
-
BRIEF: EHang reports wider loss, slashes 2025 revenue guidance
EH.US
-
BRIEF: Meitu reports strong profit growth in first half of 2025
1357.HK
- China’s robotaxi commercialization faces hidden barriers
-
Tuya accelerates AI strategy with 93% of shipped products featuring full AI integration
TUYA.US2391.HK
